About certara inc - CERT
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
CERT At a Glance
Certara, Inc.
4 Radnor Corporate Center
Radnor, Pennsylvania 19087
| Phone | 1-415-237-8772 | Revenue | 418.84M | |
| Industry | Packaged Software | Net Income | -1,595,000.00 | |
| Sector | Technology Services | 2025 Sales Growth | 8.747% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,576 | |
| View SEC Filings |
CERT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 3.374 |
| Price to Book Ratio | 1.319 |
| Price to Cash Flow Ratio | 14.67 |
| Enterprise Value to EBITDA | 15.15 |
| Enterprise Value to Sales | 3.651 |
| Total Debt to Enterprise Value | 0.20 |
CERT Efficiency
| Revenue/Employee | 265,760.152 |
| Income Per Employee | -1,012.056 |
| Receivables Turnover | 3.602 |
| Total Asset Turnover | 0.267 |
CERT Liquidity
| Current Ratio | 2.054 |
| Quick Ratio | 2.054 |
| Cash Ratio | 1.235 |
CERT Profitability
| Gross Margin | 48.027 |
| Operating Margin | 6.152 |
| Pretax Margin | 1.818 |
| Net Margin | -0.381 |
| Return on Assets | -0.102 |
| Return on Equity | -0.15 |
| Return on Total Capital | -0.117 |
| Return on Invested Capital | -0.117 |
CERT Capital Structure
| Total Debt to Total Equity | 28.74 |
| Total Debt to Total Capital | 22.324 |
| Total Debt to Total Assets | 19.623 |
| Long-Term Debt to Equity | 28.093 |
| Long-Term Debt to Total Capital | 21.821 |